J4 ›› 2012, Vol. 38 ›› Issue (4): 784-787.

• 临床医学 • 上一篇    下一篇

利用VMAT放疗技术治疗恶性脑胶质瘤时血脑屏障通透性的变化

张 矛|金海国|苏清秀|卜明伟|李玉平|刘贵刚   

  1. 吉林省肿瘤医院放疗三科|吉林 长春130012
  • 收稿日期:2012-02-24 出版日期:2012-07-28 发布日期:2012-07-16
  • 通讯作者: 张 矛( Tel:0431-85877258, E-mail:zm19621127@sina.com) E-mail:zm19621127@sina.com
  • 作者简介:张 矛(1962-)|男|吉林省长春市人|主任医师|从事肿瘤放射治疗学的研究。
  • 基金资助:

    吉林省科技厅自然科学基金资助课题(201015235)

ZHANG Mao,JIN Hai-guo, SU Qing-xiu|BU Ming-wei, LI Yu-ping,LIU Gui-gang   

  1. Third Department of Radiation Oncology, Cancer Hospital of Jilin Province, Cha
    ngchun 130012, China
  • Received:2012-02-24 Online:2012-07-28 Published:2012-07-16

摘要:

目的:研究利用容积弧形旋转调强(VMAT)技术对脑胶质瘤进行放疗时,血脑屏障透性的变化规律,探讨选择性开放血脑屏障的可行性。方法:选取8例接受VMAT技术进行放疗的脑胶质瘤(WHOⅡ-Ⅳ级胶质瘤)术后患者,放疗处方剂量全部为PTV:60 Gy/30 f。采用99mTc-DTPA核素在放疗前、放疗30 和50 Gy及放疗结束后2周进行脑断层显像,在照射靶区内(P)、靶区周围正常脑组织区(N)以及颅骨周围软组织外本底区(B)设置相同的感兴趣区,采集各区的放射性计数,分别计算不同时间照射靶区内、靶区周围正常脑组织的放射性计数与本底区域放射性计数的比值。结果:放疗前P/B、N/B比值分别为121.2±51.1和82.6±42.3;放疗30 Gy时其比值分别为243.6±115.4和88.4±53.2;放疗50 Gy时其比值分别为256.5±110.6和92.6±49.8;放疗结束后2周其比值分别为239.3±105.9和86.4±45.2。30和50 Gy组及放疗结束后2周组分别与放疗前组比较,P/B比值差异有统计学意义(P<0.05);N/B虽然较放疗前组有所增高,但差异无统计学意义(P>0.05)。结论:采用VMAT技术对脑胶质瘤术后患者进行照射时,周围正常脑组织保护较好,血脑屏障通透性改变不明显。但靶区内血脑屏障通透性明显增加,可选择性开放血脑屏障,在介入化疗药物时可减轻正常脑组织的损伤。

关键词: 容积弧形旋转调强;血脑屏障;脑胶质瘤;99mTc-DTPA

Abstract:

Abstract:Objective  To study the changes of blood-brain barrier permeability during radiotherapy of brain glioma with volumetric modulated arc therapy(VMAT),and to explore the feasibility to selectively open the blood brain barrier.Methods Eight patients with postoperative glioma (WHO Ⅱ - Ⅳ grade glioma)  received VMAT were selected,all the patients received PTV 60 Gy/30 f dose prescriptions.99mTc-DTPA brain SPECT was performed before and during radiotherapy 30 Gy,50 Gy and 2 weeks after the end of irradiation.A frame of transverse 99mTc-DTPA brain SPECT image that best displayed the gliomas was chosen,and the regions of radiation(P),normal brain tissue around the radiation area(N) and the background outside the soft tissues around the cranium(B)were collected.The radioactive counts of every area were measured and the ratios of the total counts(P/B and N/B
) before and during radiotherapy 30 Gy,50 Gy and 2 weeks after the end of irradiation were calculated.
Results The average ratios of P/B and N/B were 121.2±51.1 and 82.6±42.3 before radiotherapy,and  243.6±115.4 and 88.4±53.2 during radiotherapy 30 Gy,and 256.5±110.6 and 92.6±49.8 during radiotherapy 50 Gy,and 239.3±105.9 and 86.4±45.2 at 2 weeks after the end of radiotherapy,respectively.Compared with before radiotherapy,the P/B in radiotherapy 30 Gy,50 Gy and 2 weeks after the end of irradiation groups had statistically significant differences (P<0.05);compared with before radiotherapy,the N/B in radiotherapy 30 Gy,50 Gy and 2 weeks after the end of irradiation groups had no statistically significant differences (P> 0.05).Conclusion
When VMAT technology is used in the patients with glioma, the  protection of the normal brain tissue is better, and the change of blood-brain barrier permeability is not obvious. However, the permeability of the regions
 of radiation increases significantly, and the blood-brain barrier should be selectively opened, which can reduce normal brain tissue damage for interventions with chemotherapy.

Key words: volumetric modulated arc therapy;blood-brain barrier;glioma;99mTc-DTPA

中图分类号: 

  •